ARCHIVES

AACI Told Medicare “Probably” Has Paid For Extra Patient Care Costs Of Research; Members Object To “Two Level System”

This article is from The Cancer Letter archive.

Vol. 10 No. 30 | July 27, 1984

Download PDF Visit The Full Archive

Related Articles

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho

October 26, 2012

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

Pittsburgh Investigates Use of Resources in Anonymous Mailing To Researchers

April 29, 1994

Clinical Center Director Plans Revitalization of Research Training

December 9, 1994